Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-17 06:10 am Purchase | 13G | aTYR PHARMA INC ATYR | Aspire Capital Fund LLC | 1,312,537 9.150% | 1,312,537 (New Position) | View |
| 2020-12-23 4:42 pm Purchase | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | Aspire Capital Fund LLC | 270,000 5.050% | 270,000 (New Position) | View |
| 2020-07-02 06:21 am Purchase | 13G | Akari Therapeutics Plc AKTX | Aspire Capital Fund LLC | 673,580,900 19.890% | 673,580,900 (New Position) | View |
| 2020-07-02 06:19 am Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Aspire Capital Fund LLC | 20,680,882 6.110% | 20,680,882 (New Position) | View |